It is a chemicals private limited company based in Pune, Maharashtra, India, established in 2022.
2022 | Pune, Maharashtra, India | ActiveMedbro 5 India Pharmaceuticals Private Limited, a active private limited company, was established on 06 July 2022 in Pune, Maharashtra, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24230PN2022PTC212841. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.12 M and a paid-up capital of ₹0.12 M.
Its leadership includes Mahesh Narayan Kakade (Director), Kailas Abasaheb Payghan (Director), Naresh Raghunath Sonawane (Director). Past directors included Bhausaheb Tukaram Jadhav, Arjun Dnyanoba Chavan, Dattahari Gangadharrao Bhosle. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at S. No. 44, Hissa No. 5, Plot No\O. 31 Near Masjid,, Pune, Maharashtra, 411014.
U24230PN2022PTC212841
212841
06 July 2022
₹0.12 M
₹0.12 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Medbro 5 India Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mahesh Narayan Kakade | Director | 06 Jul 2022 | Current |
| Kailas Abasaheb Payghan | Director | 06 Jul 2022 | Current |
| Naresh Raghunath Sonawane | Director | 06 Jul 2022 | Current |
| Kapil Jayant Deshpande | Director | 23 Oct 2025 | Current |
| Akshay Gorakshanath Kamble | Director | 23 Oct 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Dec 2023 | Past |
| Pramod Abcsdd | Director | 01 Dec 2023 | Past |
| Pramod Abcsdd | Director | 01 Dec 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Medbro 5 India Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Medbro 5 India Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Medbro 5 India Pharmaceuticals has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Medbro 5 India Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medbro 5 India Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Kapil Jayant Deshpande was appointed as a Director was appointed as a Director on 23 Oct 2025 & has been associated with this company since 1 month 24 days . was recorded as a recent event.
The activity Akshay Gorakshanath Kamble was appointed as a Director was appointed as a Director on 23 Oct 2025 & has been associated with this company since 1 month 24 days . was completed.
Medbro 5 India Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Medbro 5 India Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was completed.
Progress on Mahesh Narayan Kakade was appointed as a Director was appointed as a Director on 06 Jul 2022 & has been associated with this company since 3 years 5 months . was documented.
Progress on Kailas Abasaheb Payghan was appointed as a Director was appointed as a Director on 06 Jul 2022 & has been associated with this company since 3 years 5 months . was documented.
The CIN of Medbro 5 India Pharmaceuticals Private Limited is U24230PN2022PTC212841.
Medbro 5 India Pharmaceuticals Private Limited is headquartered at S. No. 44, Hissa No. 5, Plot No\O. 31 Near Masjid,, Pune, Maharashtra, 411014.
Medbro 5 India Pharmaceuticals Private Limited was incorporated on 06 July 2022.
The current directors of Medbro 5 India Pharmaceuticals Private Limited are
The primary industry of Medbro 5 India Pharmaceuticals Private Limited is Chemicals.
Medbro 5 India Pharmaceuticals Private Limited is unlisted.
The authorized capital of Medbro 5 India Pharmaceuticals Private Limited is ₹0.12 M, and the paid-up capital is ₹0.12 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX